Literature DB >> 15788005

Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement.

P Chopard1, J Dörffler-Melly, U Hess, W A Wuillemin, D Hayoz, A Gallino, E B Bachli, C R Canova, J Isenegger, R Rubino, H Bounameaux.   

Abstract

AIM OF THE STUDY: To examine the frequency and adequacy of thromboprophylaxis in acutely ill medical patients hospitalized in eight Swiss medical hospitals.
METHODS: A cross-sectional study of 1372 patients from eight Swiss hospitals was carried out. After exclusion of patients (275) given therapeutic anticoagulation, 1097 patients were audited. The adequacy of thromboprophylaxis was assessed by comparison with predefined explicit criteria.
RESULTS: Of 1097 patients, 542 (49.4%) received thromboprophylaxis. According to the explicit criteria, 644 (58.7%) should have been on prophylaxis (P < 0.001, when compared with the rate observed). The rate of prevention differed widely between hospitals (from 29.4 to 88.6%) with no difference between teaching and nonteaching hospitals. According to the explicit criteria, a substantial proportion (44.9%) of the patients who should have been treated were not. Conversely, 41.3% of the patients were unnecessarily treated.
CONCLUSIONS: Even though the appropriateness of the explicit criteria used could be challenged, our data suggest that the current practice is associated with important uncertainty leading to both overuse and underuse of thromboprophylaxis in patients hospitalized in medical wards. More efforts are urgently needed to develop new or endorse existing explicit, evidence-based criteria and guidelines for thromboprophylaxis in this population of patients.

Entities:  

Mesh:

Year:  2005        PMID: 15788005     DOI: 10.1111/j.1365-2796.2005.01455.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

1.  Identifying, monitoring and reducing preventable major bleeds in the hospital setting.

Authors:  Deborah Caraballo; Alex C Spyropoulos; Charles E Mahan
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

2.  Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers.

Authors:  P E Beeler; E Eschmann; A Schumacher; J-D Studt; B Amann-Vesti; J Blaser
Journal:  J Am Med Inform Assoc       Date:  2014-03-26       Impact factor: 4.497

Review 3.  Management of venous thromboembolism in the elderly.

Authors:  Alex C Spyropoulos; Geno Merli
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  The appropriateness of enoxaparin use in Lebanese hospitals: a quality evaluation study.

Authors:  A A Zeitoun; J G Nassif; M M Zeineddine
Journal:  Int J Clin Pharm       Date:  2011-09-10

5.  Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience.

Authors:  H N Abdel-Razeq; S B Hijjawi; S G Jallad; B A Ababneh
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

6.  Venous thromboembolism in nursing home residents: role of selected risk factors.

Authors:  Cynthia L Leibson; Tanya M Petterson; Carin Y Smith; Kent R Bailey; Aneel A Ashrani; John A Heit
Journal:  J Am Geriatr Soc       Date:  2012-08-06       Impact factor: 5.562

Review 7.  Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.

Authors:  Franklin A Michota
Journal:  J Gen Intern Med       Date:  2007-09-22       Impact factor: 5.128

8.  Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium.

Authors:  Audrey Vervacke; Sophie Lorent; Serge Motte
Journal:  Int J Clin Pharm       Date:  2014-08-03

9.  Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.

Authors:  Paolo Prandoni
Journal:  Thromb J       Date:  2008-09-09

Review 10.  Primary prevention of venous thromboembolism in elderly medical patients.

Authors:  Karine Lacut; Gregoire Le Gal; Dominique Mottier
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.